The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

IMM IMMUPHARMA PLC ORD 10P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  0.03 0.02 0.00 0.00 0.19
Operating Profit/(Loss)  -4.18 -3.84 -4.18 -4.23 -3.43
Net Interest  0.00 0.00 0.00 0.00 0.01
Profit Before Tax  -2.47 -3.61 -4.17 -4.43 -3.34
Profit After Tax  -1.98 -3.36 -3.84 -3.69 -2.87
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -1.98 -3.36 -3.84 -3.69 -2.87
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -1.98 -3.36 -3.84 -3.69 -2.87
 
Continuing EPS
Earnings per Share - Basic  -2.44p -4.12p -4.71p -4.52p -3.43p
Earnings per Share - Diluted  -2.44p -4.12p -4.71p -4.52p -3.43p
Earnings per Share - Adjusted  -2.44p -4.12p -4.71p -4.52p -3.43p
Continuing and Discontinued EPS
Earnings per Share - Basic  -2.44p -4.12p -4.71p -4.52p -3.43p
Earnings per Share - Diluted  -2.44p -4.12p -4.71p -4.52p -3.43p
Earnings per Share - Adjusted  -2.44p -4.12p -4.71p -4.52p -3.43p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  0.08 0.13 0.12 0.10 0.37
Intangible Assets  0.71 0.67 0.63 0.60 0.56
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  0.78 0.79 0.74 0.70 0.93
Current Assets
Inventories  0.00 0.00 0.00 0.00 0.00
Trade & Other Receivables  1.18 1.32 0.87 1.11 0.72
Cash at Bank & in Hand  15.59 12.17 8.89 5.40 5.42
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  16.77 13.49 9.77 6.51 6.15
 
Total Assets  17.55 14.28 10.51 7.21 7.07
 
Liabilities
Current Liabilities
Borrowings  -0.04 -0.01 -0.25 -0.35 -0.42
Other Current Liabilities  -0.78 -0.94 -0.80 -0.68 -0.57
  -0.81 -0.95 -1.05 -1.03 -0.99
 
Net Current Assets  15.96 12.54 8.71 5.48 5.15
 
Non-Current Liabilities
Borrowings  -0.77 -0.83 -1.04 -0.77 -0.38
Provisions  0.00 0.00 0.00 0.00 0.00
Other Non-Current Liabilities  0.00 0.00 0.00 0.00 0.00
  -0.77 -0.83 -1.04 -0.77 -0.38
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -1.58 -1.77 -2.09 -1.80 -1.37
 
Net Assets  15.97 12.51 8.42 5.40 5.71
 
Capital & Reserves
Share Capital  8.15 8.15 8.15 8.23 8.86
Share Premium Account  7.45 7.45 7.45 7.77 10.49
Other Reserves  -3.22 -3.33 -3.58 -3.35 -3.54
Retained Earnings  3.60 0.24 -3.61 -7.24 -10.11
Shareholders Funds  15.97 12.51 8.42 5.40 5.71
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  15.97 12.51 8.42 5.40 5.71

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  -35.66 -19.81 -11.36 -13.94 -14.87
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  0.04p 0.02p 0.00p 0.00p 0.22p
Pre-Tax Profit per Share  -3.05p -4.43p -5.11p -5.43p -4.00p
Operating Margin  -7762.50% -21605.88% n/a n/a -1837.30%
Return on Capital Employed  -15.37% -28.50% -45.87% -74.89% -56.01%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  18.72p 14.52p 9.55p 5.84p 5.80p
Net Gearing  -92.59% -90.62% -90.34% -79.18% -81.16%

Data is provided by Morningstar


Company Information
Updated Monthly
Company address 50 Broadway, Westminster, London, SW1H 0BL, United Kingdom
Company website http://www.immupharma.c...
Market cap(in millions)* £ 36.34
Listing/Admission to trading 17 Feb 2006
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-Sep-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 5,000
SEDOL 3371101
ISIN number GB0033711010



IMMUPHARMA share - fundamentals